ClinicalTrialsFinder

KMT2A Rearrangement Clinical Trials in Boston, Massachusetts

1 recruitingBoston, Massachusetts

Showing 1–1 of 1 trials

Recruiting
Phase 1

Ziftomenib Maintenance Post Allo-HCT

Acute Myeloid LeukemiaAcute Myeloid Leukemia in RemissionKMT2A Rearrangement+1 more
Massachusetts General Hospital22 enrolled2 locationsNCT06440135